,element_id,text,page_number,filename,chunk_id,relevant
5,3dff5bf0dd3d987610c819245891f764,"Disruption of intestinal microbial communities appears to underlie many human illnesses, but the mechanisms that promote this dysbiosis and its adverse consequences are poorly understood. In patients who received allogeneic hematopoietic cell transplantation (allo-HCT), we describe a high incidence of enterococcal expansion, which was associated with graft-versus-host disease (GVHD) and mortality. We found that Enterococcus also expands in the mouse gastrointestinal tract after allo-HCT and",1,GvHD-paper.pdf,6,True
6,aaa0885b0f55e841fb07099e59cf25f8,"exacerbates disease severity in gnotobiotic models. Enterococcus growth is dependent on the disaccharide lactose, and dietary lactose depletion attenuates Enterococcus outgrowth and reduces the severity of GVHD in mice. Allo-HCT patients carrying lactose-nonabsorber genotypes showed compromised clearance of postantibiotic Enterococcus domination. We report lactose as a common nutrient that drives expansion of a commensal bacterium that exacerbates an intestinal and systemic inflammatory disease.",1,GvHD-paper.pdf,7,True
7,97816344e044637e689d1a6574cab252,"community of mostly anaerobic bacteria, and a hallmark of microbial imbalance (dysbiosis) observed in many disease states involves the expansion of facul- tative anaerobic bacteria (1). Enterococci are facultative anaerobes that colonize the intes- tines of almost every species, from insects to mammals (2), and make up a very small proportion (<0.1%) of the gut microbiota in healthy humans (3). However, enterococci are also pathogens; the species Enterococcus faecium and Enterococcus faecalis",1,GvHD-paper.pdf,8,True
8,43c6d0fc9904d9d1a853af41520f416c,"are impor- tant causes of multidrug-resistant infections in patients (4). In single-center studies, E. faecium has been observed to dominate the fecal microbiota of immunocompromised patients after allogeneic hematopoietic cell transplantation (allo-HCT), a curative-intent therapy for hematological malignancies (5–7). Moreover, fecal domination with vancomycin- resistant enterococci increases the risk of",1,GvHD-paper.pdf,9,True
9,1b22244d9546e48c7c6e6d5783287762,"bloodstream infection in allo-HCT patients (5, 8). Patients with severe graft-versus-host disease (GVHD) after allo-HCT have poor outcomes with only ~30% long-term survival (9). Gut microbiota perturbations caused by broad-spectrum antibiotics and a reduction in microbial diversity are associated with in- creased transplant-related mortality and lethal GVHD in humans and mice (10–13). Besides causing infections, experimental studies in gno- tobiotic mice have revealed that enterococci play an",1,GvHD-paper.pdf,10,True
10,f61465198e6440e5f43238f30249cc80,"important role in colitis (14) by stimulat- ing antigen-presenting cells and CD4+RORg+ T cell infiltration, causing intestinal inflam- mation (15). In this study, we investigated the role of enterococci in the development of acute GVHD, both in allo-HCT patients and preclinical allo-HCT mouse models.",1,GvHD-paper.pdf,11,True
12,b59c3859e6f00b6fade6679a559fc46d,"Center (MSKCC) (United States), Duke Uni- versity (United States), Hokkaido University (Japan), and University Hospital Regensburg (Germany). Patient characteristics are shown in table S1. We observed high abundance of enterococci soon after transplantation in samples from all four transplant centers (Fig. 1B and fig. S1B). We defined Enterococcus domination as relative genus abundance ≥0.3 (≥30%) in any fecal sample, following a thresh- old we have used previously (5) (materials and methods and",1,GvHD-paper.pdf,13,True
13,ba5a7cd89a0dd0e1e025134ac812d2fa,"fig. S2C). The incidence of domination rose comparably across cen- ters, with up to 65% of patients exhibiting a domination event after allo-HCT (Fig. 1A). E. faecium was the dominant species in both the MSKCC and the multicenter-validation cohort (Duke, Hokkaido, and Regensburg) (Fig. 1B, fig. S1, and table S2), where 40.1% of MSKCC patients (441 of 1101 patients) and 46.0% of multicenter-validation patients (103 of 224 patients) met criteria for domination at any time point between day −20 and",1,GvHD-paper.pdf,14,True
15,07dfeaf72aaa01606b402fc242d17978,"early posttransplant period (day 0 to +21) was associated with significantly reduced overall survival and increased GVHD-related mortality in both the MSKCC and multicenter- validation cohort, as well as an increased risk of moderate-to-severe acute GVHD in the MSKCC cohort (Fig. 1, C and D, fig. S2, A and B, and table S3). The risk of relapse or disease progression was not associated with enterococcal domination in either cohort. The association of domination by genus Enterococcus with clinical",1,GvHD-paper.pdf,16,True
16,0b3f9ba03bbc4a8ad978c5a6129cefeb,"outcomes in the MSKCC cohort remained significant in a multivariate analysis adjusted for graft source, disease, conditioning intensity, gender, and age (table S4). In a subset of MSKCC patients, the vanA operon was found in 152 (37.4%) of 406 patients that had samples available for analysis, indicating the presence of vancomycin-resistant enterococci (VRE) (fig. S2E). Notably, expansions of several different taxa were detected in fecal samples in this study, but the Enterococcus genus was the",1,GvHD-paper.pdf,17,True
27,7167bbe87dc96d8199e21579ac3e08d9,"To further investigate these clinical obser- vations, we examined the fecal microbiota of mice early after transplantation using well- established mouse models of allo-HCT. In a major histocompatibility complex (MHC)– matched, minor-antigen-mismatched allo-HCT model [C57BL/6-to-129S1/Sv transplant (C57BL/ 6→129S1/Sv)], we performed 16S rRNA gene sequencing of fecal samples and found that E. faecalis dominated the fecal microbiota at posttransplant day +8 in mice who re- ceived T cell–replete",2,GvHD-paper.pdf,28,True
29,7684a55062ee8af4fdf8d0c77304a56f,"not develop. This posttransplant expansion of enterococci was consistently found in two additional lethal GVHD models: C57BL/6→ BALB/c mice (MHC-disparate model after ir- radiation conditioning) (Fig. 2B) and LP/ J→C57BL/6 mice [MHC-matched, minor- antigen–mismatched after busulfan and cyclophosphamide conditioning (16)] (Fig. 2C). The expansion of enterococci in murine allo- HCT recipients with GVHD was accompanied by an increase in Enterococcus colony–forming units recovered from mesenteric",2,GvHD-paper.pdf,30,True
32,89027271151d4580fc1e3ab5a68f82c5,"only recently became recognized as a major human pathogen; before the 1990s it was E. faecalis that caused >90% of clinical in- fections (17). Because E. faecalis expands in mice with GVHD and is the major Enterococcus species in laboratory mice, we next investigated whether E. faecalis contributes to GVHD. We colonized germ-free C57BL/6 mice with a com- munity of six bacterial strains (Akkermansia muciniphila, Lactobacillus johnsonii, Blautia producta, Bacteroides sartorii, Clostridium bolteae,",2,GvHD-paper.pdf,33,True
33,0196242abc12beb7b4005908f58cc2d7,"and Parabacteroides diastonis; see materials and methods) (10, 18, 19) 21 days prior to allo-HCT (LP/J→gnotobiotic C57BL/6). One group of mice was cocolonized on day −21 with E. faecalis OG1RF, which remained detectable in mouse feces on days 0 and +7 (Fig. 2D, right panel, and fig. S4E). GVHD was exacerbated in E. faecalis–harboring mice",2,GvHD-paper.pdf,34,True
48,9e19d279e6827f592f18b6b5d4434fdd,"Overall survival 1.0 0.8 g n i v i v 0.6 r u s n o i t 0.4 r o p o Enterococcus ≥ 0.3 (n=149) r p < 0.3 (n=389) Enterococcus 0.2 HR, 1.97; p < 0.001 0 15 10 5 0 20 months after HCT

1.0 0.8 g n i v i 0.6 v r u s n o i 0.4 t r o p Enterococcus ≥ 0.3 (n=54) o r p Enterococcus < 0.3 (n=113) 0.2 HR, 1.95; p = 0.03 0 0 5 15 20 10 months after HCT",2,GvHD-paper.pdf,49,True
62,828e3d7554e59588cca8ddf4d1db363a,"GVHD-related mortality Enterococcus ≥ 0.3 (n=53) < 0.3 (n=111) Enterococcus 0.2 HR, 5.8; p = 0.002 e c n e 0.15 d i c n i e 0.1 v i t a l u m 0.05 u c 0 20 5 15 10 0",2,GvHD-paper.pdf,63,True
63,9699d347d90b3ff6d6ed7bf145b4b245,"point represents a fecal sample, and color indicates the different Enterococcus spp.; the red dotted line indicates the threshold for domination set at a relative abundance ≥0.3. (C) Overall survival (left) and cumulative incidence of GVHD- related mortality (right) in the T cell replete graft recipients in the MSKCC patient cohort (see table S3), stratified into nondominated and Enterococcus- dominated groups (domination is defined as the relative genus abundance ≥0.3 in at least one sample",2,GvHD-paper.pdf,64,True
64,10ac17b617ed6906ffae7f3f788f203e,"between day 0 and +21). n, number of individuals. (D) Overall survival (left) and cumulative incidence of GVHD-related mortality (right) in Enterococcus-dominated (at genus level) versus nondominated allo-HCT patients in the combined multicenter-validation cohort (table S3). Clinical outcomes in (C) and (D) were analyzed using the R packages survival and cmprsk. Wald values of P <0.05 signify higher risks (HR, hazard ratios) of mortality among patients with Enterococcus domination as compared",2,GvHD-paper.pdf,65,True
73,51c5aab43d05e63127bbe42b6cc4ad68,"BM+T 100 10"" ° 1 3x10* — BM (n=20) 102 107 2x10* — BM+T ® 50 102 10¢ g Enterococcus el.abundance 10+ A 19 o CFUs/g stool CFUs/mLN 1x10* 10° ° ) 10° o p<0.001 10 -1 4 7 10 10 7 10 0 5 10 15 20 days after HCT days after HCT days after HCT days after HCT c LP/J C57BL/6 16S rRNA feces Survival 14 days rel. to HCT o before bu/cy-cond 100 @ before HCT VVVYVYY v 1074 e BM ® BM+T — BM (n=9) AAA 1074 ¥ 50 g — BM+T (n=10) V busulfan g 'V cyclophosphamide Enterococcus rel. abundance 10° o 8 HCT p<0.01 10",3,GvHD-paper.pdf,74,True
87,31cddea802aa517fb42fe13a7a3f3d9b,"A allo HCTin AML patients pre HCT (diverse) == pre HCT/ non-dom. (i M Enterococcus == post HCT/ domin. { . . . Pyrimidine déoxyriboncl. salvage [ B Akkermansia Superpath. alanine biosyn. W Blautia ‘Guarlosine ribancl. denovo biosyn. Adenosine riboncl. denovo biosyn. [ W Clostridium Pyuvate feri. to acetate actate N Lactose and galctose degradation [N Dorea Calvin-Banson-Bassham cycld Eubacterium GDP-mannose biosyn. Superpath. Lysine, Lhreon, Lmeth. biosyn. ost HCT Glycolysis IV (E. F. domin.) I",4,GvHD-paper.pdf,88,True
94,e178c0bfbb1cf01e5c5bf1d88dda2593,day 7 after HCT = BM (n=5) == BM+T (n=5) Lactose and galactose degradation — Thiamine formation from pyrithiamine Pyrimidin deoxyriboncl. salvage Lysine iosynthesis hamnose degradation | ! s-aminoiidazole ribdncl. biosyn supepath 5+ aminoimid. fiboncl.biosyn. Inogine- Inosine- phosph biosyn. | — Peptifloglycanbigsynthesis || hosph biosyn. I I scrine and ycne biosyn. | S-adenosyL-methionne cycle | -1 0 i 2 LDA score (log 10),4,GvHD-paper.pdf,95,True
103,851447f60b5755773ad526b4c7b664ba,F Clostridum vs. Enterococcus (genera) in allo-HCT patients Kendall tau =-0.21; p<0.001 1 3 o = 3 2 B o Clostridium 3 2 rel. abundance - 0 107 107 1 Enterococcus rel. abundance,4,GvHD-paper.pdf,104,True
105,f033f8fe9746c75496976e1bbf1abb9d,"or in BHI broth pretreated with lactase. (Right) E. faecalis or E. faecium incubated in lactase-pretreated BHI were put into regular BHI broth after 8 hours to assess growth dynamics in regular BHI (gray symbols). Data are results of four experiments combined; values represent means ± SEM. (E) (Left) Fecal butyrate concentrations (means ± SEM) from pre- and posttransplant fecal samples from AML patients from MSKCC, who received allo-HCT and were selected based on a highly diverse pre-HCT",4,GvHD-paper.pdf,106,True
106,cd0db599eafc0f07ee61881be7c11af3,"microbiota and a posttransplant E. faecium domination [by 16S rRNA gene sequencing; 6 (out of 8) patients are presented in (A)]. (Right) Correlation of butyrate concentrations with relative abundances of the genus Enterococcus (n = 139 patients; 8 patients from left panel), and 131 allo-HCT patients from a dataset published by Haak et al. (28); statistical analysis was performed using Kendall’s tau rank correlation coefficient. (F) Stool samples were collected at the time of engraftment (~24",4,GvHD-paper.pdf,107,True
107,cc17c894eef552ae475edbff3d286a62,days after allo-HCT). Data show Kendall’s tau rank correlation of relative abundances of the genera Clostridium and Enterococcus from the dataset of Haak et al. (G) Butyrate concentration (mean ± SEM) in cecal contents of BALB/c mice transplanted with C57BL/6 BM or BM+T (1 × 106 T cells) at day +7 after HCT. Statistical analysis: *P < 0.05 [paired t test (E) or independent t test (F)].,4,GvHD-paper.pdf,108,True
124,cffa761b3293f1bad8dc1fd8805a8bb6,"vated and proliferating CD4+ T cells (fig. S4D; CD4+CD25+; CD4+Ki67+), and an increased number and percentage of CD4+RORg+ T helper 17 (TH17) cells in colon lamina propria (fig. S4D). Posttransplant administration of E. faecalis",5,GvHD-paper.pdf,125,True
130,dcee265dde1662d9b5135c2a51aa3aa4,"OG1RF to conventionally housed, T cell–replete bone marrow (BM+T)–transplanted BALB/c mice also aggravated GVHD (fig. S5A). These findings indicate that E. faecalis can aggravate GVHD severity.",5,GvHD-paper.pdf,131,True
138,ad6d880433115eb1b7fde6a73abfcf22,"SEM; *P < 0.05 (independent t test). (C) (Left) Relative abundance (log10) of Enterococcus (genus) by days relative to the day of antibiotic cessation (broad- spectrum antibiotics for neutropenic fever: intravenous piperacillin-tazobactam, intravenous imipenem-cilastatin, or intravenous meropenem). Box plot inserts display the median relative abundances of the genus Enterococcus of time binned in the indicated day ranges relative to antibiotic cessation; whiskers represent maximum and minimum.",5,GvHD-paper.pdf,139,True
139,0e59ef689baac0d6e83daed3d3dc10b2,"Statistical analysis of box plot data: *P < 0.05 (Wilcoxon rank test). (D) Cumulative incidence of acute GVHD grade 2 to 4 in rs4988235 SNP-genotyped MSKCC patients (T cell–depleted grafts excluded; graft source: BM/PBSC unmodified = 213 patients; cord blood = 102 patients; C/C = 175, T/C+T/T = 140). The cumulative incidence of grade 2 to 4 acute GVHD was compared between genotype groups using the R package cmprsk.",5,GvHD-paper.pdf,140,True
155,5a6c1e16a3e36906a3e2d3a8a327fc54,"We next considered whether posttransplant defects of mucosal defense mechanisms facil- itate enterococcal expansion. Immunoglobulin A (IgA) coating of intestinal bacteria can be protective in colitis and is important for maintaining mucosal integrity (20). How- ever, we did not observe members of the genus Enterococcus to be enriched in either IgA- negative or IgA-positive fecal fractions, even though total fecal IgA was significantly re- duced in allo-HCT recipients with GVHD (fig. S5, B to D).",6,GvHD-paper.pdf,156,True
156,d2fd496bdfe0b7e7b6ce33f463067ead,"Reduction of IgA by transplant- ing IgA-deficient bone marrow (BM) from activation-induced cytidine deaminase knock- out mice did not further increase enterococcal expansion (fig. S5E). Intestinal antimicrobial peptides of the Reg3 family can suppress the growth of VRE (21) and are reported to play a major role in GVHD (22). Accordingly, we found that both Reg3B/G transcripts and interleukin-22 protein, which regulates Reg3 expression (23), were reduced in the ileum of GVHD mice (fig. S5F).",6,GvHD-paper.pdf,157,True
157,f437430e0d1cd83772d368fde5605c8c,"Next, we analyzed microbiota-intrinsic fac- tors and used shotgun metagenomic sequenc- ing to characterize the metabolic potential of the Enterococcus-dominated fecal microbiota. Pre- and posttransplant fecal samples from MSKCC patients who received allo-HCT for acute myeloid leukemia were selected for sequencing on the basis of having a highly diverse pre-HCT microbiota and posttrans- plant E. faecium domination (by 16S rRNA gene sequencing). We focused on microbial metabolic pathways that",6,GvHD-paper.pdf,158,True
158,954c9a9e57f11308dd3b33e7774937ff,"specifically charac- terize domination by comparing them with the highly diverse pretransplant microbiota from the same patients. Pathways involved in DNA synthesis and, notably, in lactose and galactose degradation were enriched in the E. faecium–dominated, posttransplant micro- biota. In contrast, amino acid synthesis and starch-degradation pathways were more prev- alent in pretransplant specimens (Fig. 3A). The lactose-and-galactose degradation path- way was also significantly enriched in the",6,GvHD-paper.pdf,159,True
159,1763b36f0e868d4f3f751a78c1fadc47,posttransplant E. faecalis–dominated samples of mice with GVHD (Fig. 3B). Comparison of whole-genome sequencing from isolates of E. faecium (from a human allo-HCT patient) and of E. faecalis (from a mouse with GVHD) revealed that genes encoding lactose and galactose metabolism accounted for ~3% of their genomes (Fig. 3C). In silico analysis of these Enterococcus genomes and publicly available genomes of other members of the gnotobiotic six-strain consortium revealed that enterococci are,6,GvHD-paper.pdf,160,True
162,f40eea9163a0eafca1c765d2532619da,"infusion (BHI) broth depleted of lactose (by lactase; fig. S7A) did not grow (Fig. 3D). Growth was reinstated upon transfer to re- gular BHI, excluding antibacterial effects of lactase treatment (Fig. 3D). Enterococcal expansion after allo-HCT was accompanied by a loss of Clostridium spp. in the microbiota of allo-HCT patients (Fig. 3, A and F) and of mice with GVHD (fig. S8, A to C, and table S7). This may be important for allo-HCT patients, as high abundances of clostridia are associated with",6,GvHD-paper.pdf,163,True
163,83a84cf1c218335bbe5608707fd742dd,"better survival and low- er incidence of GVHD (12, 25). Commen- sal clostridia are known to produce large amounts of butyrate (26), which mitigates lethal GVHD in mice through protecting energy homeostasis of enterocytes (27). We observed that posttransplant enterococcal domination and a loss of clostridia were accompanied by a significant reduction in fecal butyrate in both allo-HCT patients and mice with GVHD (Fig. 3, E and G) (28). A loss of this key metabolite may contribute to the poor",6,GvHD-paper.pdf,164,True
165,b588c6e7e34cada90b753ddcecf6c937,"Given that the optimal growth of enterococci depends on lactose availability in vitro, we investigated whether enterococcal expansion can be mitigated by feeding mice lactose-free chow (fig. S7B and table S8). In the C57BL/ 6→BALB/c model, the absence of dietary lactose significantly reduced posttransplant Enterococcus bloom and mitigated GVHD (Fig. 4A and fig. S9B). Flow cytometric anal- ysis of donor T cells on day +14 revealed a reduction in the percentage of activated and proliferating CD4+",6,GvHD-paper.pdf,166,True
166,bbddbe11309e15be8746bc6e6d43c2f6,"T cells (CD4+CD69+; CD4+ Ki67+) as well as a reduction in the percent- age of CD4+Tbet+ (TH1) T cells (fig. S9). The effect of a lactose-free diet on enterococcal outgrowth and GVHD was replicated in the LP/J→C57BL/6 mouse model (Fig. 4B and table S9 for changes in non-enterococcal taxa). Intestinal mucosal damage by irradiation or allo-reactive T cells may affect the expres- sion of lactase, the enzyme found on small- intestine enterocytes that facilitates lactose absorption through",6,GvHD-paper.pdf,167,True
167,82449275e21b83a2772d56d81a11e386,"disaccharide cleavage. Duodenal lactase transcript abundance pro- gressively declined in BM+T recipients over the course of transplantation (fig. S9C), which may induce a lactose-intolerant–like state in mice, allowing nondigested lactose to reach the lower intestinal tract and serve as a car-",6,GvHD-paper.pdf,168,True
168,9580a38a6bd2010ce8455948bca92bea,"Next, we explored whether enterococci ex- pansion is associated with lactose tolerance in human allo-HCT patients by genotyping 602 patients from the MSKCC cohort with available pretransplant germline DNA sam- ples for the gene polymorphism rs4988235 (-13910*T). This single-nucleotide polymorphism (SNP) regulates lactase expression and pre- dicts lactose absorption and/or tolerance (C/T",6,GvHD-paper.pdf,169,True
170,e5a71d616a1f5fa0cabb719adc207bb7,"or T/T alleles) and malabsorption (C/C alleles) in the upper gut (29). Although abundance of the genus Enterococcus increased comparably during exposure to broad-spectrum antibiotics in both lactose absorbers and malabsorbers, enterococcal domination was significantly prolonged in malabsorbers after cessation of antibiotics (Fig. 4D and fig. S10). This finding suggests that the maintenance of enterococ- cal domination and microbiota recovery after broad-spectrum antibiotic exposure is signif-",6,GvHD-paper.pdf,171,True
172,b6a05d64d49450dd0c8ef03617fcb46d,"significant risk factor for the development of acute GVHD and for increased overall and GVHD-related mortality after allo-HCT. Our findings extend previous reports from smaller single-center analyses that posttransplant VRE bacteremia and fecal domination are associated with worse outcomes after allo-HCT (7, 8, 30). In gnotobiotic mouse models, enterococci exacerbate GVHD, consistent with previous reports of aggravated colitis in models of in- flammatory bowel disease (14) or systemic autoimmune",6,GvHD-paper.pdf,173,True
173,1c6bb1dfa8db30e79c638bec74376d1f,"responses (31). We previously identified Blautia abundance (a genus within class Clostridia) as a predictor of protection from lethal GVHD (12), whereas here we describe Enterococcus domination as a risk factor for GVHD. These two findings are noteworthy in light of our recent observa- tion that a B. producta strain can inhibit VRE growth via the production of a lantibiotic pro- tein (32). We identified a microbiota-intrinsic mechanism that is dependent on lactose uti- lization and favors the",6,GvHD-paper.pdf,174,True
174,cc33c91f1130a936ee46c6ae310e78a0,"expansion of enterococci. This process may be triggered through a loss of lactase produced by enterocytes damaged by conditioning or allo-reactive T cells. We validated this concept experimentally, by showing that depletion of lactose in vitro and in vivo inhibited enterococcal expan- sion and mitigated GVHD, and clinically, by showing that patients harboring a lactose- malabsorption allele experienced prolonged Enterococcus domination after antibiotic ex- posure. These observations in mice and",6,GvHD-paper.pdf,175,True
175,a3d4043417ac85988207774dac189cfc,"allo- HCT patients provide proof-of-concept for a novel, non–antibiotic-based therapeutic strategy, such as a lactose-free diet, to attenu- ate the outgrowth of pathobionts like enter- ococci and possibly improve clinical outcomes by modulating dietary sources of nutrients for",6,GvHD-paper.pdf,176,True
194,098e8540f566a36f09c7ff336ae43224,"project and provided validation; and C.K.S.-T., J.U.P., A.L.C.G., and M.R.M.v.d.B. prepared data presentation and wrote the manuscript with contributions from all other authors. Competing interests: M.R.M.v.d.B has received research support from Seres Therapeutics; has consulted, received honorarium from, or participated in advisory boards for Seres Therapeutics, Flagship Ventures, Novartis, Evelo, Jazz Pharmaceuticals, Therakos, Amgen, Magenta Therapeutics, Merck & Co, Inc., Acute Leukemia",7,GvHD-paper.pdf,195,True
206,95242abae2592d3655f378dd677c95b1,Lactose drives Enterococcus expansion to promote graft-versus-host disease,8,GvHD-paper.pdf,207,True
211,3a2aa0457adcaff586239378cb1d9d6e,"Allogeneic hematopoietic cell transplantation (allo-HCT) is used to treat certain hematopoietic malignancies, but patients have a risk of developing graft-versus-host disease (GVHD). Stein-Thoeringer et al. performed a large-scale analysis of more than 1300 patients treated with allo-HCT across four clinical centers (see the Perspective by Zitvogel and Kroemer). High levels of bacteria from the Enterococcus genus were associated with greater incidence of GVHD and mortality. Lactose appears to",8,GvHD-paper.pdf,212,True
212,4b00abb7d1147c6075f334a2fe5f2f66,"provide a substrate for Enterococcus growth, and patients with a lactose-malabsorption genotype had a greater abundance of Enterococcus. A lactose-free diet limited Enterococcus growth, reduced the severity of GVHD, and improved survival in gnotobiotic mouse models.",8,GvHD-paper.pdf,213,True
